Abstract

As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA), which is used for cardiocerebrovascular disease treatment. Here we found that NXT extract significantly promoted H9c2 cardiomyocyte cell autophagy involved in increased autophagy-associated gene expression leading to inhibition of mTOR signaling. Moreover, NXT extract increased PPARγ protein expression and transcription activity of H9c2 cell. Consistent with this, in PPARγ gene silenced H9c2 cells, NXT had no effect on autophagy and mTOR signaling. Furthermore, NXT/PPARγ-mediated H9c2 autophagy led to inhibition of cardiomyocyte cell hypertrophy. These findings suggest that the extract of NXT inhibited H9c2 cardiomyocyte cell hypertrophy via PPARγ-mediated cell autophagy.

Highlights

  • As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA, Z20025001), which is used for cardiocerebrovascular disease treatment [1, 2]

  • Real-Time PCR analysis shows that NXT significantly increased the autophagy-associated gene expressions including Atg16, LC3-a, LC3b, and ULK1 (Figure 1(d))

  • These findings show that NXT promoted H9c2 cardiomyocyte cell autophagy involved in increased autophagy-associated gene expressions

Read more

Summary

Introduction

As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA, Z20025001), which is used for cardiocerebrovascular disease treatment [1, 2]. Other reports show that NXT can decrease atherosclerosis associated with inhibition of dendritic cell maturation and iNOS expression [3, 4]. NXT ethanol extract decreases H2O2-mediated cardiomyocyte cell damage [6] and the development of diabetic retinopathy [7]; the effect of NXT on the cardiac hypertrophy is still unclear. Activation of autophagy pathway can inhibit cardiac hypertrophy [8]. Other report shows that PPARα regulate autophagy [14]. We found that NXT/PPARγ signaling inhibited H9c2 cardiomyocyte cell hypertrophy via autophagy

Materials and Methods
Results
Discussions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.